Domača stranAMGN34 • BVMF
add
Amgen
Prejšnji trg. dan.
58,11 R$
Letni razpon
47,13 R$ - 74,10 R$
Tržna kapitalizacija
144,56 mrd. USD
Povprečni obseg
1,14 tis.
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 8,50 mrd. | 23,18 % |
Stroški poslovanja | 3,14 mrd. | −2,61 % |
Čisti dohodek | 2,83 mrd. | 63,58 % |
Čista dobičkovnost prihodkov | 33,28 | 32,80 % |
Earnings per share | 5,58 | 12,50 % |
EBITDA | 3,45 mrd. | 24,59 % |
Efektivna davčna stopnja | 8,74 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 9,01 mrd. | −74,06 % |
Skupna sredstva | 90,88 mrd. | 0,39 % |
Skupne obveznosti | 83,36 mrd. | 0,58 % |
Celoten lastniški kapital | 7,53 mrd. | — |
Shares outstanding | 537,53 mio. | — |
Razmerje P/B | 4,15 | — |
Donosnost sredstev | 5,65 % | — |
Donosnost kapitala | 7,52 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(USD) | sep. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 2,83 mrd. | 63,58 % |
Denar iz dejavnosti | 3,57 mrd. | 29,38 % |
Denar iz naložb | −210,00 mio. | 19,85 % |
Denar iz financiranja | −3,65 mrd. | −82,09 % |
Neto sprememba denarnih sredstev | −290,00 mio. | −158,82 % |
Prost denarni tok | 2,87 mrd. | 114,60 % |
Vizitka
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.
The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983. The company is listed on the Nasdaq Global Select Market under the ticker symbol "AMGN", as well as a component of the Nasdaq-100, the Dow Jones Industrial Average, and the S&P 100 and 500 indices. Wikipedia
Generalni direktor
Datum ustanovitve
8. apr. 1980
Sedež organizacije
Spletno mesto
Zaposleni
26.700